Von Willebrand factor (VWF) A3 domain (VWF-A3)

The Von Willebrand factor (VWF) A3 domain is a specific structural region of the VWF protein that mediates the critical initial step of hemostasis by binding to subendothelial collagen (UniProt P04275). Upon vascular injury, collagen types I and III are exposed to the blood, and the VWF A3 domain acts as the primary anchor, tethering large VWF multimers to the site of damage (PubMed 15153410). This anchoring is particularly vital under high-shear stress conditions, such as those found in narrowed arteries, where it facilitates subsequent platelet capture via the VWF A1 domain (PubMed 22493297). In the context of cardiovascular disease, this interaction can lead to pathological arterial thrombosis, contributing to myocardial infarction and ischemic stroke. Therapeutic strategies targeting the A3 domain aim to inhibit this collagen-binding step to prevent thrombus formation without severely impairing the platelet-binding capacity of the A1 domain. Experimental agents like the monoclonal antibody 82D6 and the humanized version GBR 600 have demonstrated the ability to block this interaction and provide antithrombotic effects in preclinical models (PubMed 11830477). Unlike traditional antiplatelet agents, targeting the VWF-collagen axis may offer a wider therapeutic window with a potentially lower risk of systemic bleeding complications.

Other names

VWF collagen-binding domainVWF-A3 domainVon Willebrand factor A3-domainVWF-collagen interaction site

Inhibition of the interaction between the VWF A3 domain and subendothelial collagen types I and III, preventing the initial anchoring of VWF and subsequent platelet adhesion at sites of high shear stress.